Advertisements


We are Sorry, This Page doesn't Exist


BridgeBio Pharma Gets First FDA-Approval For Rare Genetic Metabolic Disorder

BridgeBio Pharma Inc (NASDAQ: BBIO) and affiliate Origin Biosciences Inc have received the read more.....»»

Category: blogSource: benzingaMar 1st, 2021

Translating passion into execution: Cure Rare Disease"s founder on the business of biotech

When a career path chooses you in the form of a pressing personal cause, passion and commitment must soon be followed by execution. And that means schooling up — quickly. I had heard the call of entrepreneurship early. I had a new Harvard B.....»»

Category: topSource: bizjournalsFeb 26th, 2021

SVB Leerink, J.P. Morgan downgrade Amicus stock after Phase 3 data for rare disease drug comes out

Shares of Amicus Therapeutics Inc. were down 23.1% in premarket trading on Friday, the day after the company said an experimental rare disease d.....»»

Category: topSource: marketwatchFeb 12th, 2021

Chinook Therapeutics receives rare pediatric disease designation for CHK-336

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 2nd, 2021

Chinook Therapeutics Nabs Rare Pediatric Disease Tag For CHK-336 In Primary Hyperoxaluria

read more.....»»

Category: blogSource: benzingaFeb 2nd, 2021

Genetic Technologies provides update on COVID-19 disease severity risk test

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 21st, 2021

Taysha gets both rare pediatric disease and orphan drug designations for TSHA-10

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 19th, 2021

Bluebird"s stock is up 5% as it details plans to separate oncology and genetic disease businesses

Shares of Bluebird Bio Inc. gained 5.1% in premarket trading on Monday after it announced plans to spin off its oncology business as a separate publicly-traded company. Bluebird will retain its genetic disease business. Bluebir.....»»

Category: topSource: marketwatchJan 11th, 2021

Seelos Therapeutics receives Rare Pediatric Disease Designation for SLS-005

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2020

The most common coronavirus symptoms in children — and how to know if they have a rare post-virus inflammatory syndrome

Getty Young people seem to be less vulnerable than older populations to the coronavirus, and tend to experience mild symptoms when they do get it.  But reports of a poorly-understood and deadly inflammatory disease.....»»

Category: topSource: businessinsiderMay 14th, 2020

Doctors in Italy have found a link between the coronavirus and the rare inflammatory disease seen in more than 100 children

Fiona Goodall / Stringer / Getty Images Doctors say there is evidence that a rare inflammatory syndrome being seen in children is connected to the novel coronavirus, according to a new study in .....»»

Category: topSource: businessinsiderMay 14th, 2020

What to know about Kawasaki disease, a rare condition in children that doctors worry is linked to the coronavirus

Getty Images Kawasaki disease is a rare illness that causes inflammation in the walls of arteries throughout the body. The disease occurs in one in 10,000 children under the age of fiv.....»»

Category: topSource: businessinsiderMay 6th, 2020

15 New York City children have been hospitalized with a rare disease that doctors fear is linked to the coronavirus

Mike Segar/Reuters 15 children were hospitalized in New Yo.....»»

Category: topSource: businessinsiderMay 5th, 2020

BioMarin Strikes Gene Therapy Partnership Targeting Rare Genetic Cardiomyopathies

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is beefing up its gene therapy portfolio.  read more.....»»

Category: blogSource: benzingaMay 4th, 2020

Nanocap Soligenix Rips Higher On Licensing Of COVID-19 Vaccine Adjuvant

Shares of rare disease biopharma Soligenix, Inc. (NASDAQ: SNGX) were spiking higher Thursday after the company announced a coronavirus-related licensing agreement.  read more.....»»

Category: blogSource: benzingaApr 16th, 2020

Alnylam, Dicerna Join Forces to Take on Arrowhead

Companies in race to find treatment for genetic disease that can cause lung and liver diseaseRelated Stocks: ALNY, DRNA, ARWR, NTLA, VRTX, NVO, ALXN, LLY, RHHBY,.....»»

Category: blogSource: gurufocusApr 6th, 2020

Chris Caddell, CEO of Heritage Bank, dies at 53

For the second time in five months, the well-known Caddell family of Northern Kentucky bankers has lost one of its own. Chris Caddell, chairman and CEO of Erlanger-based Heritage Bank, died from a rare degenerative brain disease on April 1, accord.....»»

Category: topSource: bizjournalsApr 6th, 2020

Former gene-silencing rivals bury the hatchet with new partnership

Former foes Alnylam Pharmaceuticals and Dicerna Pharmaceuticals Inc. are joining forces, with plans to work together on multiple gene-silencing drugs.  Alnylam (Nasdaq: ALNY) and Dicerna (Nasdaq: DRNA) say they'll work to treat a genetic disease called.....»»

Category: topSource: bizjournalsApr 6th, 2020

Ultragenyx Pharmaceutical (RARE) Shares Cross Above 200 DMA

Market News Video.....»»

Category: topSource: redinewsApr 2nd, 2020

Pink eye could be an overlooked symptom of COVID-19, eye health experts say

Clarissa Leahy/Getty Images Pink eye could be a rare symptom of COVID-19, the disease the coronavirus causes, accordin.....»»

Category: topSource: businessinsiderApr 1st, 2020